Early Access — free while we kick the tires
EdgarHawk

Lenk Robert P

Director

Director
1 filing analyzed · 1 company · Latest 2025-08-25

Companies

Company Buys Sells Direction
PLUS THERAPEUTICS, INC. PSTV 1 0 Net buying

Activity

August 2025
high
Buy
110,000 shares
$53,779
Significance 8/10

Director Robert P Lenk bought 110,000 shares of PSTV at $0.49 (2025-08-22); prior 5 trades at this ticker show 100% 90-day success rate.

Director Robert P Lenk purchased 110,000 shares at $0.49, increasing his holdings from 29.3K to 139.3K shares (+375.1% increase). This represents a substantial accumulation at a price well below the 52-week high of $46.25. His prior trade history at this specific ticker is notably consistent: across 5 prior purchases at PSTV, all 5 trades showed positive 90-day returns (range +1860.8% to +3676.2%), establishing a 100% timing success rate at this ticker. His cross-ticker open-market track record similarly shows 9 prior buys with an average 90-day return of +2831.0% and a 100% win rate. The current stock price of $12.13 is down 8.4% over 30 days and -73.8% from its 52-week high, creating a substantially depressed entry point relative to recent price action. However, the company reported a latest quarterly revenue of $1,390,000.00 with positive net income of $5,151,000.00, though it was unprofitable over its most recent full fiscal year, presenting a mixed fundamental picture.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access